在连续流动左心室辅助器件中,右心室衰竭和心声预测器的比例:系统性审查和元分析
Maria Benedetto1, Giulia Piccone1, Ludovica Nardozi1
1Anaesthesiology and Intensive Care, Cardiothoracic and Vascular Department, IRCSS Azienda Ospedaliero-Universitaria Di Bologna, Via Albertoni 15, Bologna, Italy.
Indian journal of thoracic and cardiovascular surgery
|August 1, 2023
概括
连续流动左心室辅助装置 (CF-LVAD) 植入后的右心室衰竭 (RVF) 在28.25%的患者中发生. 像TAPSE,FAC和RVGLS这样的心声学参数可以预测RVF风险.
科学领域:
- 心脏病学 心脏病学
- 心血管外科心血管外科
- 医疗成像医学成像
背景情况:
- 右心室衰竭 (RVF) 是连续流动左心室辅助装置 (CF-LVAD) 植入后的一种严重并发症,与死亡率的增加有关.
- 确定RVF的手术前预测因子对于改善患者的治疗结果至关重要.
研究的目的:
- 确定CF-LVAD患者中RVF的总比重.
- 确定最能与RVF发展相关的术前心声学参数.
主要方法:
- 2008年至2019年间发表的观察性研究的系统审查和元分析.
- 在多个电子数据库进行的研究,包括MEDLINE,EMBASE,PubMed和Cochrane图书馆.
- PRISMA流程图方法用于确保19项相关研究的系统选择.
主要成果:
- 在1741名患者的综合人群中,RVF的总比重为28.25% (95%CI:0.24-0.34).
- 在RVF和非RVF组之间观察到三环状平面缩外流 (TAPSE),部分面积变化 (FAC) 和右心室全球纵向应变 (RVGLS) 的显著变化.
- 标准化平均偏差表明TAPSE (SMD: -0.33),FAC (SMD: -0.34) 和RVGLS (SMD: 0.52) 与RVF之间的相关性.
结论:
- 术前心声学参数,特别是TAPSE,FAC和RVGLS,在CF-LVAD植入后显示与RVF相关的趋势.
- 虽然预测因素仍然不确定,但这些心声回声测量为风险分层提供了潜在的见解.
- 需要进一步的研究,以充分阐明这些参数在预测CF-LVAD后RVF中的作用.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure II: Pathophysiology
15
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15
Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16


